MiT family translocation renal cell carcinomas: A 15th anniversary update

Area of Science:

• Oncology
• Genetics
• Pathology

Background:

• Microphthalmia (MiT) family translocation renal cell carcinomas (RCCs) are a group of kidney tumors defined by MiT transcription factor expression.
• These tumors arise from chromosomal translocations or gene amplification and include subtypes like Xp11 translocation RCC and t(6;11) RCC.

Purpose of the Study:

• To review literature on MiT family translocation RCCs over the past 15 years.
• To highlight the clinical, pathological, molecular, and prognostic heterogeneity of these tumors.
• To identify the need for greater understanding of molecular mechanisms driving tumor behavior.

Main Methods:

• Literature review of scientific articles published in the last 15 years.
• Analysis of clinical, pathological, and molecular data of MiT family translocation RCCs.

Main Results:

• MiT family translocation RCCs exhibit significant heterogeneity in clinical presentation, pathology, molecular features, and prognosis.
• Despite recognition in 2004, the molecular underpinnings of their diverse behaviors remain incompletely understood.

Conclusions:

• Further investigation into the molecular mechanisms is crucial for identifying prognostic biomarkers.
• Understanding tumor aggression in MiT family translocation RCCs requires deeper molecular insights.